NDC 65162-415 – Buprenorphine HCl and Naloxone HCl

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC65162-415

Product details

Brand name
Buprenorphine HCl and Naloxone HCl
Generic name
Buprenorphine and Naloxone
Labeler
Amneal Pharmaceuticals LLC
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203136
Marketed since
February 22, 2013
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine HCl and Naloxone HCl →

Package NDC codes (2)

Package NDCDescriptionSince
65162-415-0330 TABLET in 1 BOTTLE (65162-415-03)Feb 22, 2013
65162-415-0990 TABLET in 1 BOTTLE (65162-415-09)Feb 22, 2013

Other Buprenorphine HCl and Naloxone HCl products